United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $964,180,770.30
Most recent insider trade:
  • Feb. 25, 2026
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 8, 2015CEO9,662$122.48Sell$1,183,401.76
Oct. 7, 2015CEO2,211$120.88Sell$267,265.68
Oct. 5, 2015CEO2,592$126.88Sell$328,872.96
Oct. 1, 2015CEO6,326$131.11Sell$829,401.86
Oct. 1, 2015EVP6,000$129.38Sell$776,280.00
Oct. 1, 2015Director3,000$131.32Sell$393,960.00
Sept. 29, 2015Director5,000$139.19Sell$695,950.00
Sept. 29, 2015CEO2,592$134.25Sell$347,976.00
Sept. 24, 2015CEO9,662$139.26Sell$1,345,530.12
Sept. 23, 2015CEO2,211$142.05Sell$314,072.55
Sept. 21, 2015CEO2,592$150.81Sell$390,899.52
Sept. 17, 2015CEO9,662$152.02Sell$1,468,817.24
Sept. 16, 2015CEO2,211$151.93Sell$335,917.23
Sept. 14, 2015CEO2,592$153.08Sell$396,783.36
Sept. 10, 2015CEO4,115$152.95Sell$629,389.25
Sept. 9, 2015CEO2,211$152.77Sell$337,774.47
Sept. 8, 2015CEO2,592$152.80Sell$396,057.60
Sept. 3, 2015Director3,000$155.54Sell$466,620.00
Sept. 3, 2015CEO9,662$153.67Sell$1,484,759.54
Sept. 2, 2015CEO2,211$151.12Sell$334,126.32
Aug. 31, 2015CEO2,592$153.50Sell$397,872.00
Aug. 27, 2015CEO9,662$160.37Sell$1,549,494.94
Aug. 26, 2015CEO2,211$155.47Sell$343,744.17
Aug. 24, 2015CEO2,592$155.36Sell$402,693.12
Aug. 20, 2015CEO9,662$166.58Sell$1,609,495.96
Aug. 19, 2015CEO2,211$167.13Sell$369,524.43
Aug. 17, 2015CEO2,592$166.61Sell$431,853.12
Aug. 13, 2015CEO9,662$165.05Sell$1,594,713.10
July 27, 2015CEO2,592$166.38Sell$431,256.96
July 23, 2015CEO4,115$176.38Sell$725,803.70
July 22, 2015CEO2,211$174.55Sell$385,930.05
July 20, 2015CEO2,592$177.92Sell$461,168.64
July 16, 2015CEO9,662$175.51Sell$1,695,777.62
July 15, 2015CEO2,211$176.77Sell$390,838.47
July 13, 2015CEO2,592$172.42Sell$446,912.64
July 9, 2015CEO9,662$168.04Sell$1,623,602.48
July 8, 2015CEO2,211$167.13Sell$369,524.43
July 6, 2015CEO2,592$170.66Sell$442,350.72
July 2, 2015Director3,000$171.59Sell$514,770.00
July 2, 2015CEO6,326$170.69Sell$1,079,784.94
June 29, 2015CEO2,592$172.86Sell$448,053.12
June 25, 2015CEO9,662$176.91Sell$1,709,304.42
June 24, 2015CEO2,211$179.68Sell$397,272.48
June 22, 2015CEO2,592$188.64Sell$488,954.88
June 18, 2015Director15,000$185.60Sell$2,784,000.00
June 18, 2015CEO9,662$185.72Sell$1,794,426.64
June 17, 2015CEO2,211$185.25Sell$409,587.75
June 15, 2015CEO2,592$185.15Sell$479,908.80
June 11, 2015CEO9,662$183.76Sell$1,775,489.12
June 10, 2015CEO2,211$180.87Sell$399,903.57
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Michael Benkowitz, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, James Edgemond, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Paul A. Mahon, Jan Malcolm, Ray Kurzweil, Tommy G. Thompson, MAHON PAUL A, Louis Sullivan, Judy D. Olian, R Paul Gray, and DWEK RAYMOND

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 393 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $386,981,200.91.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Feb. 25, 2026.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $10,679,625.00 on Feb. 9, 2026.